The store will not work correctly when cookies are disabled.
3-{[4-(4-Fluorophenyl)piperazin-1-yl]methyl}-2,5,7-trimethylimidazo[1,2-c]pyrimidine
ID: ALA549638
PubChem CID: 45270861
Max Phase: Preclinical
Molecular Formula: C20H24FN5
Molecular Weight: 353.44
Molecule Type: Small molecule
This compound is available for customization.
Associated Items:
Names and Identifiers
Canonical SMILES: Cc1cc2nc(C)c(CN3CCN(c4ccc(F)cc4)CC3)n2c(C)n1
Standard InChI: InChI=1S/C20H24FN5/c1-14-12-20-23-15(2)19(26(20)16(3)22-14)13-24-8-10-25(11-9-24)18-6-4-17(21)5-7-18/h4-7,12H,8-11,13H2,1-3H3
Standard InChI Key: RTYGYVMXTLAVMS-UHFFFAOYSA-N
Molfile:
RDKit 2D
26 29 0 0 0 0 0 0 0 0999 V2000
8.4784 -4.1458 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
8.4784 -4.9708 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.7639 -5.3833 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.7639 -3.7333 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.0495 -4.1458 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
7.0495 -4.9708 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.2648 -5.2258 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
5.7799 -4.5583 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.2648 -3.8909 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.9549 -4.5583 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.0099 -3.1063 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.2029 -2.9348 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
4.9480 -2.1501 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.1410 -1.9786 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.5890 -2.5917 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
3.8439 -3.3763 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.6509 -3.5479 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.7820 -2.4202 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.2300 -3.0333 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.4230 -2.8617 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.1681 -2.0771 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.7201 -1.4640 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.5271 -1.6356 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.1929 -5.3833 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.7639 -2.9083 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.3611 -1.9056 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
2 3 2 0
3 6 1 0
1 2 1 0
5 4 1 0
6 7 2 0
12 17 1 0
13 14 1 0
14 15 1 0
15 16 1 0
16 17 1 0
7 8 1 0
8 9 2 0
18 19 2 0
9 5 1 0
19 20 1 0
4 1 2 0
20 21 2 0
8 10 1 0
21 22 1 0
5 6 1 0
22 23 2 0
23 18 1 0
15 18 1 0
9 11 1 0
2 24 1 0
4 25 1 0
11 12 1 0
12 13 1 0
21 26 1 0
M END
Associated Targets(Human)
Associated Targets(non-human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 353.44 | Molecular Weight (Monoisotopic): 353.2016 | AlogP: 3.12 | #Rotatable Bonds: 3 |
Polar Surface Area: 36.67 | Molecular Species: NEUTRAL | HBA: 5 | HBD: ┄ |
#RO5 Violations: ┄ | HBA (Lipinski): 5 | HBD (Lipinski): ┄ | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: ┄ | CX Basic pKa: 6.96 | CX LogP: 1.69 | CX LogD: 1.55 |
Aromatic Rings: 3 | Heavy Atoms: 26 | QED Weighted: 0.72 | Np Likeness Score: -2.00 |
References
1. Linz S, Müller J, Hübner H, Gmeiner P, Troschütz R.. (2009) Design, synthesis and dopamine D4 receptor binding activities of new N-heteroaromatic 5/6-ring Mannich bases., 17 (13): [PMID:19481941] [10.1016/j.bmc.2009.05.015] |